Folgen
Christoph Beglinger
Christoph Beglinger
Zugehörigkeit unbekannt
Bestätigte E-Mail-Adresse bei tmr.ch
Titel
Zitiert von
Zitiert von
Jahr
Maintaining remission of ulcerative colitis with the probiotic Escherichia coli Nissle 1917 is as effective as with standard mesalazine
W Kruis, P Frič, J Pokrotnieks, M Lukáš, B Fixa, M Kaščák, MA Kamm, ...
Gut 53 (11), 1617-1623, 2004
16592004
Effect of laparoscopic sleeve gastrectomy vs laparoscopic Roux-en-Y gastric bypass on weight loss in patients with morbid obesity: the SM-BOSS randomized clinical trial
R Peterli, BK Wölnerhanssen, T Peters, D Vetter, D Kröll, Y Borbély, ...
Jama 319 (3), 255-265, 2018
11142018
A Meta-Analysis of the Effect of Glucagon-Like Peptide-1 (7–36) Amide on Ad Libitum Energy Intake in Humans
C Verdich, A Flint, JP Gutzwiller, E Naslund, C Beglinger, PM Hellstrom, ...
The Journal of Clinical Endocrinology & Metabolism 86 (9), 4382-4389, 2001
8902001
European evidence based consensus on the diagnosis and management of Crohn’s disease: definitions and diagnosis
EF Stange, SPL Travis, S Vermeire, C Beglinger, L Kupcinkas, K Geboes, ...
Gut 55 (suppl 1), i1-i15, 2006
8612006
Natural history of primary eosinophilic esophagitis: a follow-up of 30 adult patients for up to 11.5 years
A Straumann, H Spichtin, L Grize, KA Bucher, C Beglinger, H Simon
Gastroenterology 125 (6), 1660-1669, 2003
8552003
Improvement in glucose metabolism after bariatric surgery: comparison of laparoscopic Roux-en-Y gastric bypass and laparoscopic sleeve gastrectomy: a prospective randomized trial
R Peterli, B Wölnerhanssen, T Peters, N Devaux, B Kern, ...
Annals of surgery 250 (2), 234-241, 2009
7902009
Glucagon-like peptide-1: a potent regulator of food intake in humans
JP Gutzwiller, B Göke, J Drewe, P Hildebrand, S Ketterer, D Handschin, ...
Gut 44 (1), 81-86, 1999
7311999
Glucagon-like peptide-1 promotes satiety and reduces food intake in patients with diabetes mellitus type 2
JP Gutzwiller, J Drewe, B Göke, H Schmidt, B Rohrer, J Lareida, ...
American Journal of Physiology-Regulatory, Integrative and Comparative …, 1999
6991999
Fecal calprotectin correlates more closely with the Simple Endoscopic Score for Crohn's disease (SES-CD) than CRP, blood leukocytes, and the CDAI
AM Schoepfer, C Beglinger, A Straumann, M Trummler, SR Vavricka, ...
Official journal of the American College of Gastroenterology| ACG 105 (1 …, 2010
6932010
Metabolic and hormonal changes after laparoscopic Roux-en-Y gastric bypass and sleeve gastrectomy: a randomized, prospective trial
R Peterli, RE Steinert, B Woelnerhanssen, T Peters, C Christoffel-Courtin, ...
Obesity surgery 22, 740-748, 2012
6382012
Anti-interleukin-5 antibody treatment (mepolizumab) in active eosinophilic oesophagitis: a randomised, placebo-controlled, double-blind trial
A Straumann, S Conus, P Grzonka, H Kita, G Kephart, C Bussmann, ...
Gut 59 (01), 21-30, 2010
6122010
Guidelines on the diagnosis and management of iron deficiency and anemia in inflammatory bowel diseases#
C Gasche, A Berstad, R Befrits, C Beglinger, A Dignass, K Erichsen, ...
Inflammatory bowel diseases 13 (12), 1545-1553, 2007
6072007
Budesonide is effective in adolescent and adult patients with active eosinophilic esophagitis
A Straumann, S Conus, L Degen, S Felder, M Kummer, H Engel, ...
Gastroenterology 139 (5), 1526-1537. e1, 2010
5792010
Ghrelin, CCK, GLP-1, and PYY (3–36): secretory controls and physiological roles in eating and glycemia in health, obesity, and after RYGB
RE Steinert, C Feinle-Bisset, L Asarian, M Horowitz, C Beglinger, N Geary
Physiological reviews 97 (1), 411-463, 2017
5732017
Glucagon-like peptide 1 induces natriuresis in healthy subjects and in insulin-resistant obese men
JP Gutzwiller, S Tschopp, A Bock, CE Zehnder, AR Huber, M Kreyenbuehl, ...
The Journal of Clinical Endocrinology & Metabolism 89 (6), 3055-3061, 2004
5162004
Endoscopist-directed administration of propofol: a worldwide safety experience
DK Rex, VP Deenadayalu, E Eid, TF Imperiale, JA Walker, K Sandhu, ...
Gastroenterology 137 (4), 1229-1237, 2009
5092009
Effect of peptide YY3–36 on food intake in humans
L Degen, S Oesch, M Casanova, S Graf, S Ketterer, J Drewe, C Beglinger
Gastroenterology 129 (5), 1430-1436, 2005
4722005
Long-term budesonide maintenance treatment is partially effective for patients with eosinophilic esophagitis
A Straumann, S Conus, L Degen, C Frei, C Bussmann, C Beglinger, ...
Clinical gastroenterology and hepatology 9 (5), 400-409. e1, 2011
4352011
Escalating incidence of eosinophilic esophagitis: a 20-year prospective, population-based study in Olten County, Switzerland
P Hruz, A Straumann, C Bussmann, P Heer, HU Simon, M Zwahlen, ...
Journal of Allergy and Clinical Immunology 128 (6), 1349-1350. e5, 2011
4102011
Insulin resistance causes inflammation in adipose tissue
M Shimobayashi, V Albert, B Woelnerhanssen, IC Frei, D Weissenberger, ...
The Journal of clinical investigation 128 (4), 1538-1550, 2018
4012018
Das System kann den Vorgang jetzt nicht ausführen. Versuchen Sie es später erneut.
Artikel 1–20